We first examined the expression and activation of the aPKC isoforms in primary human CML stem and progenitors (CML CD34+) and in B-ALL B-cell progenitors (CD34+/CD19+). This evidence concerns the gene CD19 and chronic myelogenous leukemia, BCR-ABL1 positive.